National survey on bacterial meningitis in children

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to investigate the epidemiology of bacterial meningitis in children, focusing on the bacteria responsible for the condition. It will collect data from clinical cases that show signs of meningitis and have positive results from cerebrospinal fluid cultures or tests. The study will help understand how the epidemiology of bacterial meningitis has evolved, particularly in light of the use of various conjugate vaccines. By gathering this information, the study seeks to inform better treatment recommendations and public health strategies.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* clinical signs of meningitis, associated with positive cerebrospinal fluid (CSF) culture and/or positive CSF antigen testing (Escherichia coli K1, N. meningitidis serogroups B, A, C, Y and W-135, group B streptococci, Hib, or S. pneumoniae), and/or positive CSF polymerase chain reaction (PCR), and/or positive blood culture with CSF pleocytosis (\> 10 cells/µL).
* purpura fulminans

Exclusion Criteria:

\-

Where it's running

• Activ
  Créteil, France Recruiting

Study contacts

• Principal investigator: Robert Cohen — Association Clinique Thérapeutique Infantile du val de Marne
• Study coordinator: Corinne Levy, MD
• Email: corinne.levy@activ-france.fr
• Phone: 0033148850404

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Evaluating the impact of pneumococcal vaccination on invasive infections in children

  This study is trying to see how well the pneumococcal vaccines are working to protect children from serious infections caused by pneumococcus.

  Recruiting Association Clinique Thérapeutique Infantile du val de Marne · Créteil · NCT04664556

• Group-based Emotional Awareness and Expression Therapy to Support Recovery After Acquired Brain Injury

  A group therapy program based on EAET is tested to see if it helps adults 18-65 with acquired brain injury improve emotional well-being and daily functioning.

  Recruiting Uppsala University · Uppsala · NCT07852936

• Task-oriented training with ankle stimulation to improve balance in children with hemiparesis

  This study tests whether combining task-focused training with electrical stimulation of the ankle dorsiflexor muscles helps improve balance in children with hemiparesis.

  Recruiting Cairo University · Damietta · NCT07648511

• Biomarkers linked to congenital CMV using newborn blood spots

  Researchers will test protein and RNA markers in dried blood spots from newborns to see if they can identify congenital CMV sequelae early.

  Recruiting at 2 sites Copenhagen University Hospital, Rigshospitalet · Copenhagen and 1 other locations · NCT07635368

• Meningococcal vaccine for children 12–23 months old (Group ACYW135)

  This study tests whether the new Group ACYW135 meningococcal vaccine in healthy children aged 12 to 23 months can provoke a similar immune response and has an acceptable safety profile compared with a licensed vaccine.

  Recruiting at 2 sites Phase 3 Sinovac Biotech Co., Ltd · Nanning, Guangxi and 1 other locations · NCT07505836

• Group ACYW135 meningococcal vaccine in children 6-11 months

  This trial tests whether the investigational meningococcal vaccine in healthy infants aged 6 to 11 months can provoke a strong immune response with good safety compared with a licensed vaccine.

  Recruiting at 2 sites Phase 3 Sinovac Biotech Co., Ltd · Nanning, Guangxi and 1 other locations · NCT07505823

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.